High Times
Home > Boards > US Listed > Medical - Drugs >

Allergan (AGN)

AGN RSS Feed
Add AGN Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 9/14/2018 3:14:18 PM - Followers: 9 - Board type: Free - Posts Today: 0
High Times
AGN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
AGN News: FDA Approves Medicines360's sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for ... 09:00 AM
AGN News: Allergan To Present Data From 13 Abstracts At The 2018 American Society For Dermatologic Surgery Meeting In Phoenix 10/11/2018 04:15:00 PM
AGN News: Allergan Presents New Research at the American College of Gastroenterology Annual Scientific Meeting (ACG 2018) 10/08/2018 08:00:00 AM
AGN News: Allergan Launches Personalized Study Approach for Clinical Research Programs in Inflammatory Bowel Disease 10/05/2018 07:30:00 AM
AGN News: Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting® 10/04/2018 07:30:00 AM
News News Alert: FDA Approves Medicines360's sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for ... 10/16/2018 09:00:00 AM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#168  Sticky Note AGN slides from Medical Aesthetics Day: DewDiligence 09/14/18 03:14:18 PM
#168   AGN slides from Medical Aesthetics Day: DewDiligence 09/14/18 03:14:18 PM
#167   Re: AGN's internal long-acting toxin DewDiligence 09/14/18 11:20:39 AM
#166   AGN acquires (private) Bonti for $195M plus contingencies: DewDiligence 09/14/18 10:12:43 AM
#165   AGN receives CRL for Ulipristal treatment for uterine fibroids: DewDiligence 08/21/18 05:56:09 PM
#164   AGN, EDIT announce mutual opt-ins on EDIT-101: #msg-142720697. DewDiligence 08/06/18 04:19:22 PM
#163   More granularity of 2Q18 Botox sales: #msg-142479825. DewDiligence 07/27/18 08:34:42 AM
#162   Transcript of AGN 2Q18 CC: DewDiligence 07/27/18 08:33:47 AM
#161   AGN 2Q18 items… DewDiligence 07/26/18 12:09:02 PM
#160   AGN/MOLN.SW report phase-3 AMD data for Abicipar (a/k/a DARPin): DewDiligence 07/19/18 11:17:15 AM
#159   AGN 1Q18 CC transcript: DewDiligence 05/01/18 02:12:35 PM
#158   Good earnings but, we’re down.... did I miss something? sjgolf1967 04/30/18 07:43:16 PM
#157   AGN 1Q18 items… DewDiligence 04/30/18 10:10:33 AM
#156   Update http://www.scotusblog.com/2018/04/opinion-analysis-justices-rebuff-const KarinCA 04/26/18 02:15:43 AM
#155   RVNC Investor Day PR and slide set: DewDiligence 04/21/18 09:24:58 AM
#154   $AGN - Mohawk Tribe wins stay from Federal KarinCA 03/29/18 05:10:24 AM
#153   $AGN Update on their move to protect patent KarinCA 03/16/18 01:22:38 PM
#152   RVNC, MYL collaborate on Botox biosimilar: DewDiligence 02/28/18 06:34:28 PM
#151   AGN 4Q17 items… DewDiligence 02/06/18 08:35:26 AM
#150   Thanks for the heads up T695 01/22/18 08:13:24 PM
#149   There's a lot of discussion of AGN (especially DewDiligence 01/22/18 04:23:11 PM
#148   This stock has been moving nicely, I’m surprised T695 01/22/18 04:19:15 PM
#147   1/12/18 Morningstar rpt on AGN (quite comprehensive): DewDiligence 01/12/18 10:07:25 AM
#146   AGN webcast at JPM—>1/8/18, 6pm ET. DewDiligence 12/30/17 07:00:18 AM
#145   Maybe the reversal starts today T695 11/29/17 07:42:34 AM
#144   Why is this board not connected to the ticker?? T695 11/06/17 10:47:08 AM
#143   Transcript of AGN’s 3Q17 CC: DewDiligence 11/02/17 03:47:59 PM
#142   anyone looking to buy today? rcookr1 11/02/17 09:12:46 AM
#141   3Q17 worldwide Botox sales=$775M: #msg-135855769. DewDiligence 11/01/17 09:31:50 AM
#140   AGN 3Q17 CC slides: DewDiligence 11/01/17 08:35:46 AM
#139   $AGN - Allergan Was Correct To Fight The KarinCA 10/23/17 02:07:04 PM
#138   Adverse ruling on Restasis patent in US District Court: DewDiligence 10/16/17 02:04:54 PM
#137   AGN, PFE settle Restasis-patent litigation: #msg-135360904. DewDiligence 10/12/17 07:00:57 PM
#136   AGN authorizes $2B buyback and increased dividend: #msg-134875241. DewDiligence 09/25/17 10:03:39 AM
#135   AGN reports mixed phase-2b NASH data: DewDiligence 09/22/17 10:50:59 AM
#134   https://seekingalpha.com/article/4107923-amgen-allergan-avastin-biosimilar-appro Inoviorulez 09/19/17 06:50:06 PM
#133   AGN’s novel ploy to protect Restasis exclusivity: #msg-134477923. DewDiligence 09/08/17 12:52:50 PM
#132   AGN 2Q17 CC slides: DewDiligence 08/03/17 12:34:50 PM
#131   2Q17 Botox sales by category: #msg-133533732. DewDiligence 08/03/17 11:58:05 AM
#130   ODAC endorsed AMGN/AGN’s Avastin FoB by unanimous vote: DewDiligence 07/13/17 07:24:32 PM
#129   AGN 1Q17 items… DewDiligence 05/09/17 10:12:37 AM
#128   Does AGN have a way around the new hiwatt1959 04/23/17 07:33:44 PM
#127   NVS, AGN collaborate on phase-2b for NASH combo: #msg-130568056. DewDiligence 04/18/17 11:00:09 AM
#126   AGN moves Botox to phase-3 in depression despite DewDiligence 04/05/17 06:17:01 PM
#123   Why Kybella has disappointed: #msg-129497650. DewDiligence 03/14/17 11:41:00 AM
#122   AGN, EDIT ink drug-discovery collaboration for eye diseases: #msg-129491806. DewDiligence 03/14/17 09:29:49 AM
#121   FDA approves Noctiva for frequent nighttime urination: #msg-129243463. DewDiligence 03/06/17 10:39:48 AM
#120   4Q16 Botox sales: $729M, +14% YoY: #msg-128533148. DewDiligence 02/08/17 12:15:11 PM
#119   AGN 4Q16 items… DewDiligence 02/08/17 11:44:38 AM
#118   Option pricing suggest a move of ~$10 or nowlurking 02/07/17 10:33:43 AM
#117   Allergan $AGN valuation models shows 14% upside b4 ValueInvestor15 02/07/17 09:28:19 AM
PostSubject